Deoxycytidine kinase (dCK) inhibition is synthetic lethal with BRCA2 deficiency-Reference-Cited by-同舟云学术

Deoxycytidine kinase (dCK) inhibition is synthetic lethal with BRCA2 deficiency

Published:2023-03 Issue: Volume:67 Page:100932
ISSN:1368-7646
Container-title:Drug Resistance Updates
language:en
Short-container-title:Drug Resistance Updates

Author:

Guantay Laura,Garro Cintia,Siri Sebastián,Pansa María Florencia,Ghidelli-Disse Sonja,Paviolo Natalia,Racca Ana,Nicotra Viviana,Radu Caius,Bocco José Luis,Felice Rosana,Jansson Keith H.,Remlinger Katja,Amador Alejandro,Stronach Euan,Coleman Kevin,Muelbaier Marcel,Drewes Gerard,Gloger Isro,Madauss Kevin,García Manuela,Gottifredi Vanesa,Soria Gastón

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Cancer Research,Pharmacology,Oncology

Reference69 articles.

1. Homologous recombination in DNA repair and DNA tolerance;Li;Cell Res,2008

2. Brca1 controls homology-directed DNA repair;Moynahan;Mol. Cell,1999

3. BRCA2 is required for homology-directed repair of chromosomal breaks;Moynahan;Mol. Cell,2001

4. Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11;Schlacher;Cell,2011

5. Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins;Prakash;Cold Spring Harb. Perspect. Biol.,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Uniform Ribosome Display Technology Enabling Easy and Efficient Identification of Full‐Length Proteins that Interact with Bioactive Small and Large Molecules;ChemBioChem;2024-09-12

2. Dynamic immunoediting by macrophages in homologous recombination deficiency-stratified pancreatic ductal adenocarcinoma;Drug Resistance Updates;2024-09

3. Butterfly Effect in Cytarabine: Combined NMR-NQR Experiment, Solid-State Computational Modeling, Quantitative Structure-Property Relationships and Molecular Docking Study;Pharmaceuticals;2024-03-29

4. Overexpression of ABCC1 and ABCG2 Confers Resistance to Talazoparib, a Poly (ADP-Ribose) Polymerase Inhibitor;Drug Resistance Updates;2023-11